MetaCap

Pro-Dex Inc. (PDEX)

NASDAQ: PDEXHealth CareMedical/Dental InstrumentsUSD

63.00-0.49 (-0.77%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PDEX stock chart

Technical analysis

Key statistics

All statistics
Market cap
$201.60M
52-week range
32.14 – 77.00
Day range
61.96 – 63.55
Volume / Avg
53.56K / 54.15K
Beta
—

52-week range

$32.14$77.00

PDEX stock today

Pro-Dex (PDEX) closed at $63.00 on Nov 20, down 0.77% (-$0.49), versus the S&P 500's 3.70% decline. Shares are 18.2% below their 52-week high of $77.00, set on Sep 4, 2026 and 96.0% above the 52-week low of $32.14, in the middle of the past year's range. PDEX is up 63.7% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 92.9%.

Pro-Dex trades at 17.4x its trailing twelve-month earnings per share of $3.63. Its forward P/E of 18.2x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Pro-Dex

Company profile

Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.

Industry
Medical/Dental Instruments
CEO
Mr. Richard Lee Van Kirk Jr.
Headquarters
Irvine, CA
Employees
201

Financial highlights

Full financials

In fiscal 2026, Pro-Dex generated $77.5 million in revenue, up 16.5% from fiscal 2025, its 13th consecutive year of revenue growth. Net income was $13.7 million (+52.2% year over year), for a net margin of 17.6% versus a median of 13.5% in the prior 5 years. Gross margin was 31.4% (up from 29.3%) and operating margin 16.8%.

Pro-Dex annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$77.55M$66.59M$53.84M$46.09M$42.04M
Growth+16.45%+23.68%+16.83%+9.62%+10.55%
Net income$13.66M$8.98M$2.13M$7.07M$4.57M
EPS (diluted)$4.12$2.67$0.60$1.95$1.21

Analyst forecast

Forecast

Consensus (1 analysts)

strong_buy

Avg. price target

$80.00+26.98%

  • Strong buy 0
  • Buy 1
  • Hold 0
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 29, 2026
EPS actual vs est.
$0.92 vs $0.67
Surprise
+37.31%

PDEX news

All PDEX news

Pro-Dex peers

Health Care sector
PDEX peer companies
CompanyPrice% ChgMarket capCompare
KTWOK2 Capital Acquisition Corporation Class A10.130.00%$203.02Mvs PDEX
UTMDUtah Medical Products Inc.69.49-2.07%$198.01Mvs PDEX
CLPTClearPoint Neuro Inc.6.91-5.47%$221.49Mvs PDEX
ANIKAnika Therapeutics Inc.13.23-0.38%$177.22Mvs PDEX
PROFProfound Medical Corp.6.38-3.19%$233.68Mvs PDEX
OSUROraSure Technologies Inc.3.46-4.16%$238.90Mvs PDEX
OFIXOrthofix Medical Inc.6.07-4.26%$247.41Mvs PDEX
SSIISS Innovations International Inc.1.27-0.78%$254.86Mvs PDEX

Indexes, lists and sector

Pro-Dex stock FAQ

What is Pro-Dex's stock price today?

PDEX last traded at $63.00 as of Nov 20, 4:00 PM EST, down 0.77% on the day. Prices are delayed at least 15 minutes.

Does Pro-Dex pay a dividend?

No. Pro-Dex does not currently pay a regular cash dividend.

What is PDEX's P/E ratio?

PDEX trades at a trailing P/E ratio of 17.36 and a forward P/E of 18.16.

Who is Pro-Dex's CEO?

Mr. Richard Lee Van Kirk Jr. is the chief executive officer of Pro-Dex Inc., which has about 201 employees.

Has PDEX ever split its stock?

Yes. The most recent PDEX stock split was a 1-for-3 split on Jun 18, 2010.

What is the PDEX 52-week high?

The 52-week high for PDEX is $77.00 and the 52-week low is $32.14. The stock is currently 18.2% below its high.

Compare PDEX